Leading respiratory deals by biopharma companies worldwide in 2020, by value
In 2020, Oneness Biotech and LEO Pharma partnered on a 570 million U.S. dollar respiratory diseases deal, while Moderna and Vertex partnered on a 380 million U.S. dollar respiratory deal in the same year. This statistic illustrates select respiratory disease deals by biopharmaceutical companies worldwide in 2020, by deal value.